Physician profile
Ashley Powell
NPI 1194275321
$2,010.08
in general payments reported to CMS, 2019-2025
35 companies · $704 in 2025
The $704 reported for 2025 was more than what 79% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.04 · 2022: $162 · 2023: $579 · 2024: $539 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,822.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $232.92 | 2023-2025 | Ingrezza, Ongentys |
| Abbvie INC. | $194.66 | 2025 | |
| Jazz Pharmaceuticals INC. | $182.50 | 2023-2025 | |
| Amgen INC. | $105.68 | 2024-2025 | Uplizna |
| Argenx US, INC. | $104.23 | 2025 | |
| Collegium Pharmaceutical, INC. | $97.98 | 2023-2025 | Belbuca, Xtampza |
| Harmony Biosciences LLC | $94.67 | 2023 | Wakix |
| Lilly USA, LLC | $82.01 | 2023-2025 | Amyvid, Emgality, Kisunla |
| Boston Scientific Corporation | $69.52 | 2021-2023 | Infinion 16 |
| Teva Pharmaceuticals USA, INC. | $68.98 | 2023-2024 | Austedo Xr |
| Lundbeck LLC | $66.39 | 2022-2024 | Vyepti, Rexulti |
| Alexion Pharmaceuticals, INC. | $62.05 | 2023-2025 | Ultomiris, Soliris |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.38 | 2022-2024 | Relistor |
| Tanabe Pharma America, INC. | $49.26 | 2023-2024 | |
| Emd Serono, INC. | $47.98 | 2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $46.58 | 2023 | Floseal |
| Axsome Therapeutics, INC. | $42.34 | 2023 | Sunosi |
| Ucb, INC. | $40.94 | 2025 | Briviact |
| Acadia Pharmaceuticals INC | $39.71 | 2025 | Nuplazid |
| Hologic Sales and Service, LLC | $36.39 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.78 | 2025 | Hyqvia |
| Otsuka America Pharmaceutical, INC. | $20.79 | 2023 | Rexulti |
| Livanova USA, INC. | $20.56 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Kci USA, INC. | $20.28 | 2022 | |
| Scilex Pharmaceuticals INC. | $20.26 | 2024 | |
| Medtronic, INC. | $19.68 | 2023 | Mazor X System |
| Pfizer INC. | $19.62 | 2023 | |
| Janssen Biotech, INC. | $18.84 | 2025 | |
| Heron Therapeutics, INC. | $18.32 | 2025 | Zynrelef |
| Abbott Laboratories | $18.03 | 2023 | Proclaim |
| Genentech USA, INC. | $17.40 | 2024 | Ocrevus |
| Azurity Pharmaceuticals, INC. | $16.65 | 2023 | Gliadel |
| Astrazeneca Pharmaceuticals LP | $16.11 | 2025 | Wainua |
| Integra Lifesciences Corporation | $14.23 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.